MEDIPAL HOLDINGS CORP chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 15,737.95
Dividend & Yield46.00¥ (2.36%)
Beta 0.29
Market capitalization 401.84B
Operating cash flow N/A
ESG Scores unknown

Company description

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.

Sector: Healthcare - Industry: Medical Distribution

Financial data

Financial Statements

Cashflow Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Change To Liabilities -590M 14.15B 16.05B 8.26B
Total Cashflows From Investing Activities -23.51B -13.32B -2.94B -24.34B
Net Borrowings -12.95B -8.45B -3.56B -350M
Total Cash From Financing Activities -30.75B -49.07B -16B -16.47B
Change To Operating Activities -321M -281M 5.06B 5.63B
Issuance Of Stock
Net Income 34.36B 37.97B 23.93B 29.42B
Change In Cash 9.45B -5.47B 15.51B 20.4B
Effect Of Exchange Rate
Total Cash From Operating Activities 63.72B 56.92B 34.45B 61.22B
Depreciation 13.93B 14.69B 14.79B 14.34B
Change To Account Receivables 10.9B -2.7B -12.68B -10.28B
Other Cashflows From Financing Activities -3.69B -3.72B -3.62B -7.3B
Change To Netincome -23.68B -39.23B -33.73B -10.28B
Capital Expenditures -14.58B -24.3B -12.84B -15.96B

Income Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Research Development
Income Before Tax 63.46B 75.53B 49.24B 57.28B
Net Income 34.36B 37.97B 23.93B 29.42B
Selling General Administrative 170.79B 171.13B 162.91B 159.49B
Gross Profit 232.5B 236.74B 214.26B 217.44B
Ebit 49.47B 53.11B 38.58B 45.62B
Operating Income 49.47B 53.11B 38.58B 45.62B
Interest Expense -180M -137M -50M -16M
Income Tax Expense 18.04B 24.31B 15.62B 18.09B
Total Revenue 3.18T 3.25T 3.21T 3.29T
Cost Of Revenue 2.95T 3.02T 3T 3.07T
Total Other Income ExpenseNet 13.99B 22.42B 10.66B 11.66B
Net Income From Continuing Ops 45.42B 51.23B 33.62B 39.2B
Net Income Applicable To Common Shares 34.36B 37.97B 23.93B 29.42B

Balance Sheet Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Total Liabilities 1.03T 1.04T 1.04T 1.06T
Total Stockholder Equity 496.88B 500.32B 523.01B 530.3B
Other Current Liabilities 46.08B 49.92B 45.44B 63.92B
Total Assets 1.62T 1.64T 1.68T 1.71T
Common Stock 22.4B 22.4B 22.4B 22.4B
Other Current Assets 6.63B 14.95B 10.15B 13.88B
Retained Earnings 321.24B 350.56B 365.29B 385.61B
Treasury Stock 18.88B -7B 963M -11.63B
Cash 213.03B 207.54B 222.75B 243.15B
Total Current Liabilities 932.62B 945.6B 952.84B 1.01T
Other Stockholder Equity 49.35B 51.61B 59.57B 46.98B
Property, Plant, and Equipment 254.18B 265.58B 261.59B 264.37B
Total Current Assets 1.14T 1.15T 1.17T 1.21T
Net Tangible Assets 482.79B 489.27B 512.83B 520.33B
Net Receivables 751.16B 753.79B 766.86B 774.68B
Accounts Payable 869.65B 883.62B 900.01B 908B


Insider Transactions

Here are the insider transactions of stock shares related to MEDIPAL HOLDINGS CORP:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to MEDIPAL HOLDINGS CORP. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on MEDIPAL HOLDINGS CORP

Here is the result of two systematic investment strategies applied to MEDIPAL HOLDINGS CORP. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on MEDIPAL HOLDINGS CORP

The following chart shows the equity curve of the two systematic investment strategies applied to MEDIPAL HOLDINGS CORP:

MEDIPAL HOLDINGS CORP automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 0.16% on the backtest period.

Performance at glance

Performance

0.16 %

Latent gain

22.0 ¥

Invested capital

13412.0 ¥

Annualized return

0.04 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on MEDIPAL HOLDINGS CORP

This is the result of two momentum investment strategies applied to MEDIPAL HOLDINGS CORP. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on MEDIPAL HOLDINGS CORP

The following chart shows all the entries opened by the momentum investment system on MEDIPAL HOLDINGS CORP:

MEDIPAL HOLDINGS CORP momentum entries
  • The first momentum investment strategy would give 11.92% of return on MEDIPAL HOLDINGS CORP. That represents 954.0¥ of latent gain with 8002.0¥ of employed capital.
  • The second momentum investment strategy would give 3.65% of return on MEDIPAL HOLDINGS CORP. That represents 315.0¥ of latent gain with 8641.0¥ of employed capital.
Performance at glance (1Q Momentum)

Performance

11.92 %

Latent gain

954.0 ¥

Invested capital

8002.0 ¥

Annualized return

4.58 %
Performance at glance (2Q Momentum)

Performance

3.65 %

Latent gain

315.0 ¥

Invested capital

8641.0 ¥

Annualized return

0.98 %

Momentum equity curve on MEDIPAL HOLDINGS CORP

The following chart shows the equity curve of the two momentum strategies applied to MEDIPAL HOLDINGS CORP:

MEDIPAL HOLDINGS CORP momentum equity

Note: the dividends potentially given by MEDIPAL HOLDINGS CORP are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on MEDIPAL HOLDINGS CORP

The following chart shows the employed capital evolution of the two momentum strategies on MEDIPAL HOLDINGS CORP since the beginning:

MEDIPAL HOLDINGS CORP

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250¥, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000¥.


Buy the dip strategy result on MEDIPAL HOLDINGS CORP

Buy the dip entry openings on MEDIPAL HOLDINGS CORP

MEDIPAL HOLDINGS CORP

The performance achieved by the robo-advisor on MEDIPAL HOLDINGS CORP is 10.08%. That represents 615.0$ of latent gain with 6102.0¥ of employed capital. The following chart shows MEDIPAL HOLDINGS CORP stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of MEDIPAL HOLDINGS CORP, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

10.08 %

Latent gain

615.0 ¥

Invested capital

6102.0 ¥

Annualized return

4.58 %

Equity curve of the strategy applied to MEDIPAL HOLDINGS CORP

The following chart shows the result of the investment strategy applied to MEDIPAL HOLDINGS CORP:

MEDIPAL HOLDINGS CORP

Note: the dividends potentially given by MEDIPAL HOLDINGS CORP are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on MEDIPAL HOLDINGS CORP

The following chart shows the employed capital evolution since the beginning of the investment strategy on MEDIPAL HOLDINGS CORP:

MEDIPAL HOLDINGS CORP

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on MEDIPAL HOLDINGS CORP

In this section, I will compare the three previous investment strategies applied to MEDIPAL HOLDINGS CORP.

Equity curve comparison on MEDIPAL HOLDINGS CORP

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

MEDIPAL HOLDINGS CORP investment strategy comparison

Employed capital comparison on MEDIPAL HOLDINGS CORP

MEDIPAL HOLDINGS CORP investment comparison

Performance comparison on MEDIPAL HOLDINGS CORP

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 0.16% 22.0¥ 13412.0¥ 0.04%
Momentum 1 quarter 11.92% 954.0¥ 8002.0¥ 3.01%
Momentum 2 quarters 3.65% 315.0¥ 8641.0¥ 0.98%
Non-directional 10.08% 615.0¥ 6102.0¥ 4.58%
Annualized return comparison

Automatic investment

0.04 %

Momentum 1Q

0.98 %

Momentum 2Q

0.98 %

Non-directional

4.58 %

Correlated stocks

Here are the most positively and negatively correlated stocks with MEDIPAL HOLDINGS CORP:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between MEDIPAL HOLDINGS CORP and the other stocks. There may be false positives or some missing correlated stocks. If the price of MEDIPAL HOLDINGS CORP does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name MEDIPAL HOLDINGS CORP
Country Japan
City Tokyo
Address 2-7-15, Yaesu
Phone 81 3 3517 5800
Website www.medipal.co.jp
FullTime employees 12801
Industry Medical Distribution
Sector Healthcare
Exchange XTKS
Ticker 7459.XTKS
Market www.jpx.co.jp

MEDIPAL HOLDINGS CORP ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown